Ube Industries close caprolactam production at Sakai facility

Ube Industries to close caprolactam production at Sakai facility

10:53 AM, 6th February 2013
Ube Industries to close caprolactam production at Sakai facility

TOKYO, JAPAN: Ube Industries Ltd will cease production of caprolactam at the Sakai factory in Japan. The decision will result in the company recording an extraordinary loss for the fiscal year ending 31 March 2013.

With the global economic slowdown starting in 2012, growth in demand for caprolactam has weaken while market conditions for caprolactam have been heavily eroded by the entry of new manufacturers and successive production expansion of existing manufacturers centering on Chinese companies, this made the company to close the factory. At the same time, prices for raw material benzene and auxiliary materials have risen, with the net effect that the profitability of the caprolactam business has rapidly declined.

Ube will continue to supply customers with the affected products from its other manufacturing facilities, endeavoring to make the transition as smooth as possible for customers to secure their supply for another manufacturer. Employees who are currently engaged in caprolactam production at the Sakai factory will be shifted to production for specialty products including separators for lithium-ion batteries, whose production is set to be expanded at the Sakai factory.

© WOC News 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Technip bags Shell’s Gannet field project contract in North Sea

PARIS, FRANCE: Technip was awarded by Shell UK Limited, engineering, procurement, installation and construction contract for the Gannet F Reinstatemen ...

Read more
Merck, Opexa JV for Tcelna (imilecleucel-T) development

DARMSTADT, GERMANY: Merck announced the execution of an agreement with Opexa Therapeutics Inc for the development and commercialization of Tcelna (i ...

Read more
Frog in bucket of milk produces potential new antibiotics

  WASHINGTON DC, US: Following up on an ancient Russian way of keeping milk from going sour, by putting a frog in the bucket of milk, scientists ...

Read more
Jacobs renews GSK’s manufacturing facilities contract in Singapore

PASADENA, US: Jacobs Engineering Group Inc has renewed its contract with Glaxo Wellcome Manufacturing Pte Ltd (GSK) as alliance contractor a ...

Read more
IFF, Evolva collaborate for natural vanillin

NEW YORK, US: International Flavors & Fragrances Inc (IFF) and Evolva Holding SA, Reinach, Switzerland, a biosynthesis technology expert, have ent ...

Read more
Praxair to acquire NuCO2 for $1.1 billion

DANBURY, US: Praxair Inc has entered into an agreement to acquire NuCO2 INC from Aurora Capital Group, a Los Angeles, California based private equit ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X